← Orthofix Medical Inc. OFIX
Market Price
$10.32
Market Cap
$411.09M
P/E Ratio
N/A
Revenue (FY 2025)
↑2.9% YoY
$822.31M
3-Yr CAGR: 21.3%
Net Income
↑26.8% YoY
-$92.19M
Net Margin: -11.2%
Free Cash Flow
↑85.9% YoY
-$1.28M
FCF Yield: -0.31%
EPS (Diluted)
↑29.4% YoY
$-2.33
Basic: $-2.33
Return on Equity
Efficiency
-20.5%
ROA: -389.5%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (OFIX)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $409.8M | — | $321.9M | $3.1M | — | $0.17 | — | $44.7M | $28.3M | — |
| FY 2017 | $433.8M | +5.9% | $340.8M | $6.2M | +103.6% | $0.34 | +100.0% | $53.3M | $38.7M | +36.8% |
| FY 2018 | $453.0M | +4.4% | $356.4M | $13.8M | +121.9% | $0.72 | +111.8% | $49.9M | $36.3M | -6.1% |
| FY 2019 | $460.0M | +1.5% | $359.3M | $-28.5M | -306.1% | $-1.51 | -309.7% | $32.0M | $13.0M | -64.1% |
| FY 2020 | $406.6M | -11.6% | $304.7M | $2.5M | +108.8% | $0.13 | +108.6% | $74.3M | $58.8M | +351.0% |
| FY 2021 | $464.5M | +14.2% | $349.6M | $-38.4M | -1,624.8% | $-1.95 | -1,600.0% | $18.5M | $0.7M | -98.8% |
| FY 2022 | $460.7M | -0.8% | $337.2M | $-19.7M | +48.5% | $-0.98 | +49.7% | $-11.5M | $-32.9M | -4,868.4% |
| FY 2023 | $746.6M | +62.1% | $486.3M | $-151.4M | -666.6% | $-4.12 | -320.4% | $-45.8M | $-106.0M | -222.2% |
| FY 2024 | $799.5M | +7.1% | $545.9M | $-126.0M | +16.8% | $-3.30 | +19.9% | $25.8M | $-9.1M | +91.4% |
| FY 2025 | $822.3M | +2.9% | $566.0M | $-92.2M | +26.8% | $-2.33 | +29.4% | $33.3M | $-1.3M | +85.9% |
Valuation
Market Price
$10.32
Market Cap
$411.09M
Enterprise Value
$486.45M
P/E Ratio
N/A
P/B Ratio
0.93
FCF Yield
-0.31%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
68.83%
Operating Margin
-9.90%
Net Margin
-11.21%
Return on Equity (ROE)
-20.49%
Return on Assets (ROA)
-389.54%
Asset Turnover
34.75x
Revenue 3-Yr CAGR
21.30%
Financial Health & Liquidity
Current Ratio
2.40
Cash Ratio
8.32
Debt / Equity
0.350
Debt / Assets
6.650
Cash & Equivalents
$82.03M
Total Debt
$157.39M
Book Value / Share
$11.13
Cash Flow Efficiency
Operating Cash Flow
$33.35M
Capital Expenditures (CapEx)
$34.63M
Free Cash Flow
-$1.28M
OCF / Revenue
4.06%
FCF / Revenue
-0.16%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-2.33
EPS (Basic)
$-2.33
Dividends / Share
N/A
Book Value / Share
$11.13
EPS YoY Growth
29.39%
Balance Sheet (FY 2025)
Total Assets
$23.67M
Total Liabilities
$9.86M
Stockholders' Equity
$450.04M
Current Assets
$23.67M
Current Liabilities
$9.86M